Neuro-Oncology in Women: Clinical Considerations

Lauren Singer; Ditte Primdahl; Priya Kumthekar

doi:10.1016/j.ncl.2022.10.005

Neuro-Oncology in Women: Clinical Considerations

Lauren Singer^*, Ditte Primdahl, Priya Kumthekar

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	331-342
Number of pages	12
Journal	Neurologic clinics
Volume	41
Issue number	2
DOIs	https://doi.org/10.1016/j.ncl.2022.10.005
State	Published - May 2023

Funding

L. Singer has no conflicts of interest. D. Primdahl has no conflicts of interest. P. Kumthekar has had advisory roles at Biocept, Enclear, Affinia Therapeutics. P. Kumthekar served on advisory boards/advised Orbus Therapeutics, Berg, Bioclinia Sintetica, Novocure, Janssen, Angiochem, Celularity, Mirati and SDP Oncology and received research funding from Novocure, Switzerland , Genetech . P. Kumthekar holds European Patent 3,307,327, August 12, 2020 and US Patent Pending 15/737,188.

Keywords

Glioma
Meningioma
Oncology

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/j.ncl.2022.10.005

Cite this

@article{1dd92a7f02594d1ebd71f410d717eb09,

title = "Neuro-Oncology in Women: Clinical Considerations",

keywords = "Glioma, Meningioma, Oncology",

author = "Lauren Singer and Ditte Primdahl and Priya Kumthekar",

note = "Funding Information: L. Singer has no conflicts of interest. D. Primdahl has no conflicts of interest. P. Kumthekar has had advisory roles at Biocept, Enclear, Affinia Therapeutics. P. Kumthekar served on advisory boards/advised Orbus Therapeutics, Berg, Bioclinia Sintetica, Novocure, Janssen, Angiochem, Celularity, Mirati and SDP Oncology and received research funding from Novocure, Switzerland , Genetech . P. Kumthekar holds European Patent 3,307,327, August 12, 2020 and US Patent Pending 15/737,188.",

year = "2023",

month = may,

doi = "10.1016/j.ncl.2022.10.005",

language = "English (US)",

volume = "41",

pages = "331--342",

journal = "Neurologic clinics",

issn = "0733-8619",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Neuro-Oncology in Women

T2 - Clinical Considerations

AU - Singer, Lauren

AU - Primdahl, Ditte

AU - Kumthekar, Priya

N1 - Funding Information: L. Singer has no conflicts of interest. D. Primdahl has no conflicts of interest. P. Kumthekar has had advisory roles at Biocept, Enclear, Affinia Therapeutics. P. Kumthekar served on advisory boards/advised Orbus Therapeutics, Berg, Bioclinia Sintetica, Novocure, Janssen, Angiochem, Celularity, Mirati and SDP Oncology and received research funding from Novocure, Switzerland , Genetech . P. Kumthekar holds European Patent 3,307,327, August 12, 2020 and US Patent Pending 15/737,188.

PY - 2023/5

Y1 - 2023/5

KW - Glioma

KW - Meningioma

KW - Oncology

UR - http://www.scopus.com/inward/record.url?scp=85148754433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148754433&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2022.10.005

DO - 10.1016/j.ncl.2022.10.005

M3 - Review article

C2 - 37030961

AN - SCOPUS:85148754433

SN - 0733-8619

VL - 41

SP - 331

EP - 342

JO - Neurologic clinics

JF - Neurologic clinics

IS - 2

ER -

Neuro-Oncology in Women: Clinical Considerations

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this